Li Y, Zhang Q, Wang X, Liu Z, Chen H, Su Z, Xu Y, Zhang W, Du Y, Tan Z, Huang S, Liu W, Sang Z. Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD. Bioorg Chem. 2025 Apr;157:108245. Epub 2025 Feb 6 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.